Viewing Study NCT06957366

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 4:36 PM
Ignite Modification Date: 2025-12-28 @ 3:00 PM
Study NCT ID: NCT06957366
Status: RECRUITING
Last Update Posted: 2025-05-09
First Post: 2025-04-25
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Perioperative Anticoagulant Use for Surgery Evaluation -2 (PAUSE-2) Study Patients Receiving a Direct Oral Anticoagulant (DOACs-Dabigatran, Rivaroxaban, Apixaban or Edoxaban) and Needing Elective High-Bleed-Risk Surgery or an Invasive Procedure
Sponsor: McMaster University
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Atrial Fibrillation (AF) View
None VTE View
Keywords:

Keywords

Keyword Brief Keyword Text View
None anticoagulation View
None atrial Fibrillation View
None Surgery View
None Oral Anticoagulant View
None Blood thinner View
None DOAC View
None VTE View
None Interruption View
None PAUSE View